Mosqitter Expands Mosquito Traps into AI Surveillance Network
The Pennsylvania-based startup aims to use its 5,000 devices worldwide to identify species and warn of disease risk, targeting governments and public-health agencies.
Mosqitter is turning its chemical-free mosquito traps into a global AI-powered surveillance network. The move comes as the World Health Organization reports that dengue cases more than doubled from 6.5 million in 2023 to a record 14.6 million in 2024. Rising temperatures, shifting rainfall patterns and increased travel are expanding the range of disease-carrying mosquitoes, and Mosqitter says its technology can help curb the spread.
Founded in 2019 in Ukraine and launched commercially in 2021, Mosqitter is a 30-person startup headquartered in Pennsylvania. The company began by studying female mosquito behavior, noting that the insects seek blood before laying eggs and typically deposit 100 to 200 eggs every three weeks. By luring females with heat, scent, light and, in its flagship Grand model, carbon dioxide, Mosqitter traps them at the point of egg-laying, potentially reducing population growth.
The company’s current portfolio includes the Mosqitter Grand, designed for large public spaces, and the Mosqitter Mini, aimed at residential use and portable monitoring. Both devices capture mosquitoes and feed images into a neural network that identifies species. The system cross-checks results against external datasets and has entomologists validate findings, assigning a confidence score that reflects the alignment of the assessments. Mosqitter also incorporates environmental data such as weather, wind and humidity, which the company plans to use for forecasting population changes and potential health risks.
Next month Mosqitter will launch its Febris Monitoring System, a data-layer platform that offers continuous monitoring, dashboards and analytics for institutional customers. Febris does not diagnose disease but reports the presence of specific mosquito species, allowing users to gauge the risk of diseases those species can transmit. The system targets governments, public-health agencies, airports, municipalities and universities that require ongoing surveillance.
Mosqitter is pursuing B2B partners worldwide, especially distributors with established sales networks and ties to governments and retailers. In Brazil, the company has set up local manufacturing and sales operations. In Greece it works with a long-established pest-control firm, while in the United States it sells the Mini directly to consumers through Amazon and its own website. The company is also collaborating with the United Kingdom Health Security Agency to deploy Febris at Heathrow and Gatwick airports, underscoring the need for continuous monitoring in high-traffic travel hubs.
Pricing for the hardware is $199 for the Mini and $1,999 for the Grand. Mosqitter’s revenue model combines one-time hardware sales with a recurring stream from Febris, which includes monitoring services and data analytics. The startup projects more than $1 million in revenue for 2026, with the Febris data business potentially adding over $3.5 million next year based on current contract bids. Mosqitter is raising a $5 million round in two tranches, starting with $1 million and followed by $4 million, tied to milestones for the Febris system. To date the company has raised $1.9 million.
With its expanding device footprint and the launch of a data platform, Mosqitter is positioning itself as a key player in the emerging field of mosquito-borne disease surveillance. The company’s focus on sustainable, chemical-free traps and AI-driven species identification could make it an attractive partner for governments and public-health agencies looking to preempt outbreaks. The next few months will test whether the Febris